List of Tables
Table 1. Cancer Drug Therapy Market Trends
Table 2. Cancer Drug Therapy Market Drivers & Opportunity
Table 3. Cancer Drug Therapy Market Challenges
Table 4. Cancer Drug Therapy Market Restraints
Table 5. Global Cancer Drug Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cancer Drug Therapy Revenue Market Share by Company (2019-2024)
Table 7. Global Cancer Drug Therapy Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Cancer Drug Therapy Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cancer Drug Therapy Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Cancer Drug Therapy Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cancer Drug Therapy Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cancer Drug Therapy
Table 13. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Drug Therapy as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cancer Drug Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cancer Drug Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cancer Drug Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cancer Drug Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cancer Drug Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cancer Drug Therapy Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Cancer Drug Therapy Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Cancer Drug Therapy Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Cancer Drug Therapy Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cancer Drug Therapy Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cancer Drug Therapy Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Cancer Drug Therapy Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Cancer Drug Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cancer Drug Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cancer Drug Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Drug Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cancer Drug Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cancer Drug Therapy Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Cancer Drug Therapy Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Cancer Drug Therapy Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Cancer Drug Therapy Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cancer Drug Therapy Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cancer Drug Therapy Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Cancer Drug Therapy Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Cancer Drug Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cancer Drug Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cancer Drug Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cancer Drug Therapy Sales Value by Region (2019-2024) & (%)
Table 44. Global Cancer Drug Therapy Sales Value by Region (2025-2030) & (%)
Table 45. Global Cancer Drug Therapy Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Cancer Drug Therapy Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Cancer Drug Therapy Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Cancer Drug Therapy Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cancer Drug Therapy Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cancer Drug Therapy Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Cancer Drug Therapy Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Cancer Drug Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cancer Drug Therapy Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cancer Drug Therapy Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cancer Drug Therapy Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Cancer Drug Therapy Sales Volume, (2025-2030) & (K Units)
Table 57. Amgen / Allergan Company Information
Table 58. Amgen / Allergan Introduction and Business Overview
Table 59. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Amgen / Allergan Cancer Drug Therapy Product Offerings
Table 61. Amgen / Allergan Recent Development
Table 62. Argos Therapeutics Company Information
Table 63. Argos Therapeutics Introduction and Business Overview
Table 64. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Argos Therapeutics Cancer Drug Therapy Product Offerings
Table 66. Argos Therapeutics Recent Development
Table 67. AstraZeneca Company Information
Table 68. AstraZeneca Introduction and Business Overview
Table 69. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. AstraZeneca Cancer Drug Therapy Product Offerings
Table 71. AstraZeneca Recent Development
Table 72. Aveo Pharmaceuticals Company Information
Table 73. Aveo Pharmaceuticals Introduction and Business Overview
Table 74. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Aveo Pharmaceuticals Cancer Drug Therapy Product Offerings
Table 76. Aveo Pharmaceuticals Recent Development
Table 77. Bayer Company Information
Table 78. Bayer Introduction and Business Overview
Table 79. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Bayer Cancer Drug Therapy Product Offerings
Table 81. Bayer Recent Development
Table 82. Exelixis Company Information
Table 83. Exelixis Introduction and Business Overview
Table 84. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Exelixis Cancer Drug Therapy Product Offerings
Table 86. Exelixis Recent Development
Table 87. Incyte Company Information
Table 88. Incyte Introduction and Business Overview
Table 89. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Incyte Cancer Drug Therapy Product Offerings
Table 91. Incyte Recent Development
Table 92. Merck Company Information
Table 93. Merck Introduction and Business Overview
Table 94. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. Merck Cancer Drug Therapy Product Offerings
Table 96. Merck Recent Development
Table 97. Roche Company Information
Table 98. Roche Introduction and Business Overview
Table 99. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Roche Cancer Drug Therapy Product Offerings
Table 101. Roche Recent Development
Table 102. Bristol-Myers Squibb Company Information
Table 103. Bristol-Myers Squibb Introduction and Business Overview
Table 104. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. Bristol-Myers Squibb Cancer Drug Therapy Product Offerings
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Eisai Company Information
Table 108. Eisai Introduction and Business Overview
Table 109. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Eisai Cancer Drug Therapy Product Offerings
Table 111. Eisai Recent Development
Table 112. Exelixis Company Information
Table 113. Exelixis Introduction and Business Overview
Table 114. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Exelixis Cancer Drug Therapy Product Offerings
Table 116. Exelixis Recent Development
Table 117. Genentech (Roche) Company Information
Table 118. Genentech (Roche) Introduction and Business Overview
Table 119. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Genentech (Roche) Cancer Drug Therapy Product Offerings
Table 121. Genentech (Roche) Recent Development
Table 122. Novartis Company Information
Table 123. Novartis Introduction and Business Overview
Table 124. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Novartis Cancer Drug Therapy Product Offerings
Table 126. Novartis Recent Development
Table 127. Pfizer Company Information
Table 128. Pfizer Introduction and Business Overview
Table 129. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Pfizer Cancer Drug Therapy Product Offerings
Table 131. Pfizer Recent Development
Table 132. Prometheus Labs Company Information
Table 133. Prometheus Labs Introduction and Business Overview
Table 134. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Prometheus Labs Cancer Drug Therapy Product Offerings
Table 136. Prometheus Labs Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Cancer Drug Therapy Downstream Customers
Table 140. Cancer Drug Therapy Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drug Therapy Product Picture
Figure 2. Global Cancer Drug Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cancer Drug Therapy Sales Volume (2019-2030) & (K Units)
Figure 5. Global Cancer Drug Therapy Sales Price (2019-2030) & (USD/Unit)
Figure 6. Cancer Drug Therapy Report Years Considered
Figure 7. Global Cancer Drug Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cancer Drug Therapy Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Drug Therapy Revenue in 2023
Figure 10. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Targeted Therapy Picture
Figure 12. Chemotherapy Picture
Figure 13. Immunotherapy Picture
Figure 14. Global Cancer Drug Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Cancer Drug Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Cancer Drug Therapy Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Cancer Drug Therapy Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Cancer Drug Therapy Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Angiogenesis Inhibitors
Figure 20. Product Picture of mTOR Inhibitors
Figure 21. Product Picture of Monoclonal Antibodies
Figure 22. Product Picture of Cytokine Immunotherapy (IL-2)
Figure 23. Global Cancer Drug Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Cancer Drug Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Cancer Drug Therapy Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Cancer Drug Therapy Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Cancer Drug Therapy Price by Application (2019-2030) & (USD/Unit)
Figure 28. North America Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Cancer Drug Therapy Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Cancer Drug Therapy Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Cancer Drug Therapy Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Cancer Drug Therapy Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Cancer Drug Therapy Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Cancer Drug Therapy Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Cancer Drug Therapy Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Cancer Drug Therapy Sales Volume (%), (2019-2030)
Figure 40. United States Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 46. China Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 48. China Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 58. India Cancer Drug Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Cancer Drug Therapy Sales Value by Type (%), 2023 VS 2030
Figure 60. India Cancer Drug Therapy Sales Value by Application (%), 2023 VS 2030
Figure 61. Cancer Drug Therapy Industrial Chain
Figure 62. Cancer Drug Therapy Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
